Jun 19, 2013 at 11:34 | Source: Moneycontrol.com
Jun 18, 2013 at 12:56 | Source: ft.com
Jun 16, 2013 at 21:30 | Source: PTI
Jun 12, 2013 at 14:16 | Source: Moneycontrol.com
Jun 06, 2013 at 15:21 | Source: Business Wire India
Celgene Corporation has announced the US Food and Drug Administration has approved the company's supplemental new drug application for REVLIMID (lenalidomide) for the treatment of patients with mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
News across the web »
Mumbai, June 19: “Don’t sell the company, I want the legacy of my father to continue for the next 50 years,” is what Cipla doyen Y.K. Hamied told Subhanu Saxena, as the latter took ...
Jun 20, 2013 at 00:47 | Source: The Hindu BusinessLine
Nine drug companies have been fined for delaying cheaper generic drugs coming to market. The European Commission fined the Danish firm Lundbeck and others 146m euros (£125m; $195m) for blocking the s...
Jun 19, 2013 at 22:12 | Source: BBC
Nine drugmakers, including Denmark's Lundbeck and India's Ranbaxy, were fined a total of 146 million euros by EU antitrust regulators on Wednesday for blocking the supply of a cheaper anti-depressant ...
Jun 19, 2013 at 15:43 | Source: FirstPost
A Supreme Court decision Monday could lead to more challenges of deals that drug makers strike to stave off the arrival of inexpensive generic competition. The 5-3 ruling said federal regulators can ...
Jun 18, 2013 at 15:42 | Source: Market Watch
India's pharmaceutical industry suffered twin blows recently when Ranbaxy Laboratories and Wockhardt, two of the country's biggest drug makers, came under fire from US authorities. While Ranbaxy on M...
Jun 15, 2013 at 13:11 | Source: Business Today
Interact & exchange stock tips & market info »
12.17 PM May 16th